The genes discovered are in part targets of the hypoxia-sensitive transcription factors HIF1 and HIF2A and are involved in crucial pathways within the cell and may contribute to the initiation of mechanisms, which further promote the development of obesity-related diseases such as type 2 diabetes and the metabolic syndrome. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.